CoviVac, an inactivated whole-virion vaccine developed by the Russian Academy of Sciences’ Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products, was registered with the Russian Health Ministry on February 19
Overseas approval of Russia s CoviVac vaccine largely political issue, developer says tass.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tass.com Daily Mail and Mail on Sunday newspapers.
Russia may develop herd immunity against Covid-19 by first half of 2021: Report
Premium
(AFP)
Russia confirmed 21,152 COVID-19 cases in the past day, a new low since November 18
Share Via
Read Full Story
Russian Health Minister Mikhail Murashko said on Wednesday that herd immunity against COVID-19 in the country could be reached as early as the first half of this year, the RIA news agency cited him as saying. We expect collective immunity against coronavirus could be created in the first half of this year, he was cited as saying.
TRENDING STORIESSee All
2 min read
Premium
2 min read
Premium
1 min read
Russia has so far registered two domestic coronavirus vaccines
MOSCOW, December 16. /TASS/. Work on 26 coronavirus vaccine options is underway in Russia, Head of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing Anna Popova said at a meeting of the sanitary watchdog chiefs from BRICS countries. Work on 26 vaccine options is underway at 17 research centers, she pointed out.
Read also
Russia has so far registered two domestic coronavirus vaccines, one of which was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology and the other one by the State Research Center of Virology and Biotechnology Vector. A third vaccine, developed by the Russian Academy of Sciences’ Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products, may be registered in the near future.